CIK 0001766140
- Emerging growth company
Unicycive Therapeutics, Inc.
Sign in to watch- Ticker
- UNCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813638692
- Phone
- +1 650-384-0642
- Business address
- 1975 W. EL CAMINO REAL, SUITE 204, MOUNTAIN VIEW, CA, 94040
- Former names
- Unicycive Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 3,470,152 shares (conversion)
- 4 Exercise or conversion EVP of Corporate Strategy acquired 104,612 shares (option exercise)
- 4 Exercise or conversion EVP, Pharmaceuticals and BD acquired 41,845 shares (option exercise)
- 4 Exercise or conversion CEO acquired 104,612 shares (option exercise)
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 26,738 shares (option exercise)
- 4 Open-market buy Director bought 15,000 shares at $0.83 ($12,375)
Page 3 of 4 · 69 filings